Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Lilly Needs Updated FDA Authorization To Sell COVID Antibody On Commercial Market
Aug 05 2022
•
By
Sarah Karlin-Smith
Dwindling government COVID funds shifts Lilly antibody sales to commercial market • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from United States
More from North America